Document:

Note
Purchase Agreement

 

This
Note Purchase Agreement (this “Agreement”),
dated as of October 21, 2019, is entered into by and between Cancer Genetics, Inc.,
a Delaware corporation (“Company”), and Atlas Sciences, LLC, a
Utah limited liability company, its successors and/or assigns (“Investor”).

 

A.
Company and Investor are executing and delivering this Agreement in reliance upon the exemption from securities registration afforded
by the Securities Act of 1933, as amended (the “1933 Act”), and the rules and regulations promulgated thereunder
by the United States Securities and Exchange Commission (the “SEC”).

 

B.
Investor desires to purchase and Company desires to issue and sell, upon the terms and conditions set forth in this Agreement,
a Promissory Note, in the form attached hereto as Exhibit A, in the original principal amount of $1,347,500.00 (the “Note”).

 

C.
This Agreement, the Note, and all other certificates, documents, agreements, resolutions and instruments delivered to any party
under or in connection with this Agreement, as the same may be amended from time to time, are collectively referred to herein
as the “Transaction Documents”.

 

NOW,
THEREFORE, in consideration of the above recitals and other good and valuable consideration, the receipt and sufficiency of
which are hereby acknowledged, Company and Investor hereby agree as follows:

 

1.
Purchase and Sale of Note.

 

1.1.
Purchase of Note. Company hereby agrees to issue and sell to Investor and Investor hereby agrees to purchase from Company
the Note. In consideration thereof, Investor agrees to pay the Purchase Price (as defined below) to Company.

 

1.2.
Form of Payment. On the Closing Date (as defined below), Investor shall pay the Purchase Price to Company via wire transfer
of immediately available funds in accordance with the Flow of Funds schedule attached hereto as Exhibit B against delivery
of the Note.

 

1.3.
Closing Date. Subject to the satisfaction (or written waiver) of the conditions set forth in Section 5 and Section 6 below,
the date of the issuance and sale of the Note pursuant to this Agreement (the “Closing Date”) shall be October
21, 2019, or another mutually agreed upon date. The closing of the transactions contemplated by this Agreement (the “Closing”)
shall occur on the Closing Date by means of the exchange by email of .pdf documents, but shall be deemed for all purposes to have
occurred at the offices of Hansen Black Anderson Ashcraft PLLC in Lehi, Utah.

 

1.4.
Collateral for the Note. The Note shall be unsecured.

 

1.5.
Original Issue Discount; Transaction Expense Amount. The Note carries an original issue discount of $87,500.00 (the “OID”).
In addition, Company agrees to pay $10,000.00 to Investor to cover Investor’s legal fees, accounting costs, due diligence,
monitoring and other transaction costs incurred in connection with the purchase and sale of the Note (the “Transaction
Expense Amount”), all of which amount is included in the initial principal balance of the Note. The “Purchase
Price”, therefore, shall be $1,250,000.00, computed as follows: $1,347,500.00 initial principal balance, less the OID,
less the Transaction Expense Amount.

 

    	 	1	 

    	 

    

 

2.
Investor’s Representations and Warranties. Investor represents and warrants to Company that as of the Closing Date:
(i) this Agreement has been duly and validly authorized; (ii) this Agreement constitutes a valid and binding agreement of Investor
enforceable in accordance with its terms; (iii) Investor is an “accredited investor” as that term is defined in Rule
501(a) of Regulation D of the 1933 Act; and (iv) Investor has been given the opportunity to ask questions and receive answers
concerning the terms and conditions of the offering of and to obtain any additional information which Company possesses or can
acquire without unreasonable effort or expense that is necessary to verify the accuracy of the information provided to Investor.

 

3.
Company’s Representations and Warranties. Company represents and warrants to Investor that as of the Closing Date:
(i) Company is a corporation duly organized, validly existing and in good standing under the laws of its state of incorporation
and has the requisite corporate power to own its properties and to carry on its business as now being conducted; (ii) Company
is duly qualified as a foreign corporation to do business and is in good standing in each jurisdiction where the nature of the
business conducted or property owned by it makes such qualification necessary; (iii) Company has registered its shares of common
stock, $0.0001 par value per share (the “Common Stock”), under Section 12(g) of the Securities Exchange Act
of 1934, as amended (the “1934 Act”), and is obligated to file reports pursuant to Section 13 or Section 15(d)
of the 1934 Act; (iv) each of the Transaction Documents and the transactions contemplated hereby and thereby, have been duly and
validly authorized by Company and all necessary corporate actions have been taken; (v) this Agreement, the Note, and the other
Transaction Documents have been duly executed and delivered by Company and constitute the valid and binding obligations of Company
enforceable in accordance with their terms; (vi) the execution and delivery of the Transaction Documents by Company and the consummation
by Company of the other transactions contemplated by the Transaction Documents do not and will not conflict with or result in
a breach by Company of any of the terms or provisions of, or constitute a default under (a) Company’s formation documents
or bylaws, each as currently in effect, (b) any indenture, mortgage, deed of trust, or other material agreement or instrument
to which Company is a party or by which it or any of its properties or assets are bound, including, without limitation, any listing
agreement for the Common Stock, or (c) any existing applicable law, rule, or regulation or any applicable decree, judgment, or
order of any court, United States federal, state or foreign regulatory body, administrative agency, or other governmental body
having jurisdiction over Company or any of Company’s properties or assets; (vii) no further authorization, approval or consent
of any court, governmental body, regulatory agency, self-regulatory organization, or stock exchange or market or the stockholders
or any lender of Company is required to be obtained by Company for the issuance of the Note to Investor or the entering into of
the Transaction Documents; (viii) none of Company’s filings with the SEC since January 1, 2017 contained, at the time they
were filed, any untrue statement of a material fact or omitted to state any material fact required to be stated therein or necessary
to make the statements made therein, in light of the circumstances under which they were made, not misleading; (ix) since January
1, 2017, Company has filed all reports, schedules, forms, statements and other documents required to be filed by Company with
the SEC under the 1934 Act on a timely basis or has received a valid extension of such time of filing and has filed any such report,
schedule, form, statement or other document prior to the expiration of any such extension; (x) except for the shareholder suit
disclosed in the Company’s SEC filings, there is no action, suit, proceeding, inquiry or investigation before or by any
court, public board or body pending or, to the knowledge of Company, threatened against or affecting Company before or by any
governmental authority or non-governmental department, commission, board, bureau, agency or instrumentality or any other person,
wherein an unfavorable decision, ruling or finding would have a material adverse effect on Company or which would adversely affect
the validity or enforceability of, or the authority or ability of Company to perform its obligations under, any of the Transaction
Documents; (xi) Company has not consummated any financing transaction that has not been disclosed in a periodic filing or current
report with the SEC under the 1934 Act; (xii) Company is not, nor has it been at any time in the previous twelve (12) months,
a “Shell Company,” as such type of “issuer” is described in Rule 144(i)(1) under the 1933 Act; (xiii)
with respect to any commissions, placement agent or finder’s fees or similar payments that will or would become due and
owing by Company to any person or entity as a result of this Agreement or the transactions contemplated hereby (“Broker
Fees”), any such Broker Fees will be made in full compliance with all applicable laws and regulations and only to a
person or entity that is a registered investment adviser or registered broker-dealer; (xiv) Investor shall have no obligation
with respect to any Broker Fees or with respect to any claims made by or on behalf of other persons for fees of a type contemplated
in this subsection that may be due in connection with the transactions contemplated hereby and Company shall indemnify and hold
harmless each of Investor, Investor’s employees, officers, directors, stockholders, managers, agents, and partners, and
their respective affiliates, from and against all claims, losses, damages, costs (including the costs of preparation and attorneys’
fees) and expenses suffered in respect of any such claimed or existing Broker Fees; (xv) neither Investor nor any of its officers,
directors, members, managers, employees, agents or representatives has made any representations or warranties to Company or any
of its officers, directors, employees, agents or representatives except as expressly set forth in the Transaction Documents and,
in making its decision to enter into the transactions contemplated by the Transaction Documents, Company is not relying on any
representation, warranty, covenant or promise of Investor or its officers, directors, members, managers, employees, agents or
representatives other than as set forth in the Transaction Documents; (xvi) Company acknowledges that the State of Utah has a
reasonable relationship and sufficient contacts to the transactions contemplated by the Transaction Documents and any dispute
that may arise related thereto such that the laws and venue of the State of Utah, as set forth more specifically in Section 7.2
below, shall be applicable to the Transaction Documents and the transactions contemplated therein; and (xvii) Company has performed
due diligence and background research on Investor and its affiliates including, without limitation, John M. Fife, and, to its
satisfaction, has made inquiries with respect to all matters Company may consider relevant to the undertakings and relationships
contemplated by the Transaction Documents including, among other things, the following: http://investing.businessweek.com/research/stocks/people/person.asp?personId=7505107&ticker=UAHC;SEC
Civil Case No. 07-C-0347 (N.D. Ill.); SEC Civil Action No. 07-CV-347 (N.D. Ill.); and FINRA Case #2011029203701. Company, being
aware of the matters described in subsection (xvii) above, acknowledges and agrees that such matters, or any similar matters,
have no bearing on the transactions contemplated by the Transaction Documents and covenants and agrees it will not use any such
information as a defense to performance of its obligations under the Transaction Documents or in any attempt to avoid, modify
or reduce such obligations.

 

    	 	2	 

    	 

    

 

4.
Company Covenants. Until all of Company’s obligations under the Note are paid and performed in full, or within the
timeframes otherwise specifically set forth below, Company will at all times comply with the following covenants: (i) Company
will timely file on the applicable deadline all reports required to be filed with the SEC pursuant to Sections 13 or 15(d) of
the 1934 Act, and will take all reasonable action under its control to ensure that adequate current public information with respect
to Company, as required in accordance with Rule 144 of the 1933 Act, is publicly available, and will not terminate its status
as an issuer required to file reports under the 1934 Act even if the 1934 Act or the rules and regulations thereunder would permit
such termination; (ii) the Common Stock shall be listed or quoted for trading on any of (a) NYSE, (b) NASDAQ, (c) OTCQX, or (d)
OTCQB; and (iii) Company will not enter into any financing transaction with John Kirkland or any of his affiliated entities.

 

5.
Conditions to Company’s Obligation to Sell. The obligation of Company hereunder to issue and sell the Note to Investor
at the Closing is subject to the satisfaction, on or before the Closing Date, of each of the following conditions:

 

5.1.
Investor shall have executed this Agreement and delivered the same to Company.

 

5.2.
Investor shall have delivered the Purchase Price to Company in accordance with Section 1.2 above.

 

6.
Conditions to Investor’s Obligation to Purchase. The obligation of Investor hereunder to purchase the Note at the
Closing is subject to the satisfaction, on or before the Closing Date, of each of the following conditions, provided that these
conditions are for Investor’s sole benefit and may be waived by Investor at any time in its sole discretion:

 

6.1.
Company shall have executed this Agreement and the Note and delivered the same to Investor.

 

6.2.
Company shall have delivered to Investor a fully executed Secretary’s Certificate substantially in the form attached hereto
as Exhibit C evidencing Company’s approval of the Transaction Documents.

 

6.3.
Company shall have delivered to Investor fully executed copies of all other Transaction Documents required to be executed by Company
herein or therein.

 

7.
Miscellaneous. The provisions set forth in this Section 7 shall apply to this Agreement, as well as all other Transaction
Documents as if these terms were fully set forth therein; provided, however, that in the event there is a conflict between any
provision set forth in this Section 7 and any provision in any other Transaction Document, the provision in such other Transaction
Document shall govern.

 

7.1.
Arbitration of Claims. The parties shall submit all Claims (as defined in Exhibit D) arising under this Agreement
or any other Transaction Document or any other agreement between the parties and their affiliates or any Claim relating to the
relationship of the parties to binding arbitration pursuant to the arbitration provisions set forth in Exhibit D attached
hereto (the “Arbitration Provisions”). For the avoidance of doubt, the parties agree that the injunction described
in Section 7.3 below may be pursued in an arbitration that is separate and apart from any other arbitration regarding all other
Claims arising under the Transaction Documents. The parties hereby acknowledge and agree that the Arbitration Provisions are unconditionally
binding on the parties hereto and are severable from all other provisions of this Agreement. By executing this Agreement, Company
represents, warrants and covenants that Company has reviewed the Arbitration Provisions carefully, consulted with legal counsel
about such provisions (or waived its right to do so), understands that the Arbitration Provisions are intended to allow for the
expeditious and efficient resolution of any dispute hereunder, agrees to the terms and limitations set forth in the Arbitration
Provisions, and that Company will not take a position contrary to the foregoing representations. Company acknowledges and agrees
that Investor may rely upon the foregoing representations and covenants of Company regarding the Arbitration Provisions.

 

    	 	3	 

    	 

    

 

7.2.
Governing Law; Venue. This Agreement shall be construed and enforced in accordance with, and all questions concerning the
construction, validity, interpretation and performance of this Agreement shall be governed by, the internal laws of the State
of Utah, without giving effect to any choice of law or conflict of law provision or rule (whether of the State of Utah or any
other jurisdiction) that would cause the application of the laws of any jurisdiction other than the State of Utah. Each party
consents to and expressly agrees that the exclusive venue for arbitration of any dispute arising out of or relating to any Transaction
Document or the relationship of the parties or their affiliates shall be in Salt Lake County, Utah. Without modifying the parties’
obligations to resolve disputes hereunder pursuant to the Arbitration Provisions, for any litigation arising in connection with
any of the Transaction Documents, each party hereto hereby (i) consents to and expressly submits to the exclusive personal jurisdiction
of any state or federal court sitting in Salt Lake County, Utah, (ii) expressly submits to the exclusive venue of any such court
for the purposes hereof, and (iii) waives any claim of improper venue and any claim or objection that such courts are an inconvenient
forum or any other claim, defense or objection to the bringing of any such proceeding in such jurisdiction or to any claim that
such venue of the suit, action or proceeding is improper. Finally, Company covenants and agrees to name Investor as a party in
interest in, and provide written notice to Investor in accordance with Section 7.11 below prior to bringing or filing any action
(including without limitation any filing or action against any person or entity that is not a party to this Agreement) that is
related in any way to the Transaction Documents or any transaction contemplated herein or therein, and further agrees to timely
name Investor as a party to any such action. Company acknowledges that the governing law and venue provisions set forth in this
Section 7.2 are material terms to induce Investor to enter into the Transaction Documents and that but for Company’s agreements
set forth in this Section 7.2 Investor would not have entered into the Transaction Documents.

 

7.3.
Specific Performance. Company acknowledges and agrees that Investor may suffer irreparable harm in the event that Company
fails to perform any material provision of this Agreement or any of the other Transaction Documents in accordance with its specific
terms. It is accordingly agreed that Investor shall be entitled to one or more injunctions to prevent or cure breaches of the
provisions of this Agreement or such other Transaction Document and to enforce specifically the terms and provisions hereof or
thereof, this being in addition to any other remedy to which Investor may be entitled under the Transaction Documents, at law
or in equity. Company specifically agrees that following an Event of Default (as defined in the Note) under the Note, Investor
shall have the right to seek and receive injunctive relief from a court or an arbitrator prohibiting Company from issuing any
of its common or preferred stock to any party unless the Note is being paid in full simultaneously with such issuance. Company
specifically acknowledges that Investor’s right to obtain specific performance constitutes bargained for leverage and that
the loss of such leverage would result in irreparable harm to Investor. For the avoidance of doubt, in the event Investor seeks
to obtain an injunction from a court or an arbitrator against Company or specific performance of any provision of any Transaction
Document, such action shall not be a waiver of any right of Investor under any Transaction Document, at law, or in equity, including
without limitation its rights to arbitrate any Claim pursuant to the terms of the Transaction Documents, nor shall Investor’s
pursuit of an injunction prevent Investor, under the doctrines of claim preclusion, issues preclusion, res judicata or other similar
legal doctrines, from pursuing other Claims in the future in a separate arbitration.

 

7.4.
Counterparts. Each Transaction Document may be executed in any number of counterparts, each of which shall be deemed an
original, but all of which together shall constitute one instrument. The parties hereto confirm that any electronic copy of another
party’s executed counterpart of a Transaction Document (or such party’s signature page thereof) will be deemed to
be an executed original thereof.

 

7.5.
Document Imaging. Investor shall be entitled, in its sole discretion, to image or make copies of all or any selection of
the agreements, instruments, documents, and items and records governing, arising from or relating to any of Company’s loans,
including, without limitation, this Agreement and the other Transaction Documents, and Investor may destroy or archive the paper
originals. The parties hereto (i) waive any right to insist or require that Investor produce paper originals, (ii) agree that
such images shall be accorded the same force and effect as the paper originals, (iii) agree that Investor is entitled to use such
images in lieu of destroyed or archived originals for any purpose, including as admissible evidence in any demand, presentment
or other proceedings, and (iv) further agree that any executed facsimile (faxed), scanned, emailed, or other imaged copy of this
Agreement or any other Transaction Document shall be deemed to be of the same force and effect as the original manually executed
document.

 

    	 	4	 

    	 

    

 

7.6.
Headings. The headings of this Agreement are for convenience of reference only and shall not form part of, or affect the
interpretation of, this Agreement.

 

7.7.
Severability. In the event that any provision of this Agreement is invalid or unenforceable under any applicable statute
or rule of law, then such provision shall be deemed inoperative to the extent that it may conflict therewith and shall be deemed
modified to conform to such statute or rule of law. Any provision hereof which may prove invalid or unenforceable under any law
shall not affect the validity or enforceability of any other provision hereof.

 

7.8.
Entire Agreement. This Agreement, together with the other Transaction Documents, contains the entire understanding of the
parties with respect to the matters covered herein and therein and, except as specifically set forth herein or therein, neither
Company nor Investor makes any representation, warranty, covenant or undertaking with respect to such matters. For the avoidance
of doubt, all prior term sheets or other documents between Company and Investor, or any affiliate thereof, related to the transactions
contemplated by the Transaction Documents (collectively, “Prior Agreements”), that may have been entered into
between Company and Investor, or any affiliate thereof, are hereby null and void and deemed to be replaced in their entirety by
the Transaction Documents. To the extent there is a conflict between any term set forth in any Prior Agreement and the term(s)
of the Transaction Documents, the Transaction Documents shall govern.

 

7.9.
No Reliance. Company acknowledges and agrees that neither Investor nor any of its officers, directors, members, managers,
representatives or agents has made any representations or warranties to Company or any of its officers, directors, representatives,
agents or employees except as expressly set forth in the Transaction Documents and, in making its decision to enter into the transactions
contemplated by the Transaction Documents, Company is not relying on any representation, warranty, covenant or promise of Investor
or its officers, directors, members, managers, agents or representatives other than as set forth in the Transaction Documents.

 

7.10.
Amendments. No provision of this Agreement may be waived or amended other than by an instrument in writing signed by both
parties hereto.

 

7.11.
Notices. Any notice required or permitted hereunder shall be given in writing (unless otherwise specified herein) and shall
be deemed effectively given on the earliest of: (i) the date delivered, if delivered by personal delivery as against written receipt
therefor or by email to an executive officer, or by facsimile (with successful transmission confirmation), (ii) the earlier of
the date delivered or the third business day after deposit, postage prepaid, in the United States Postal Service by certified
mail, or (iii) the earlier of the date delivered or the third business day after mailing by express courier, with delivery costs
and fees prepaid, in each case, addressed to each of the other parties thereunto entitled at the following addresses (or at such
other addresses as such party may designate by five (5) calendar days’ advance written notice similarly given to each of
the other parties hereto):

 

If
to Company:

 

Cancer
Genetics, Inc.

Attn:
Jay Roberts, CEO

201
Route 17 North, 2nd Floor

Rutherford,
New Jersey 07070

 

    	 	5	 

    	 

    

 

 

With
a copy to (which copy shall not constitute notice):

 

Lowenstein
Sandler LLC

Attn:
Alan Wovsaniker

One
Lowenstein Drive

Roseland,
New Jersey 07068

 

If
to Investor:

 

Atlas
Sciences, LLC

Attn:
John Fife

303
East Wacker Drive, Suite 1040

Chicago,
Illinois 60601

 

With
a copy to (which copy shall not constitute notice):

 

Hansen
Black Anderson Ashcraft PLLC

Attn:
Jonathan K. Hansen

3051
West Maple Loop Drive, Suite 325

Lehi,
Utah 84043

 

7.12.
Successors and Assigns. This Agreement or any of the severable rights and obligations inuring to the benefit of or to be
performed by Investor hereunder may be assigned by Investor to a third party, including its affiliates, in whole or in part, without
the need to obtain Company’s consent thereto. Company may not assign its rights or obligations under this Agreement or delegate
its duties hereunder without the prior written consent of Investor.

 

7.13.
Survival. The representations and warranties of Company and the agreements and covenants set forth in this Agreement shall
survive the Closing hereunder notwithstanding any due diligence investigation conducted by or on behalf of Investor. Company agrees
to indemnify and hold harmless Investor and all its officers, directors, employees, attorneys, and agents for loss or damage arising
as a result of or related to any breach or alleged breach by Company of any of its representations, warranties and covenants set
forth in this Agreement or any of its covenants and obligations under this Agreement, including advancement of expenses as they
are incurred.

 

7.14.
Further Assurances. Each party shall do and perform, or cause to be done and performed, all such further acts and things,
and shall execute and deliver all such other agreements, certificates, instruments and documents, as the other party may reasonably
request in order to carry out the intent and accomplish the purposes of this Agreement and the consummation of the transactions
contemplated hereby.

 

7.15.
Investor’s Rights and Remedies Cumulative. All rights, remedies, and powers conferred in this Agreement and the Transaction
Documents are cumulative and not exclusive of any other rights or remedies, and shall be in addition to every other right, power,
and remedy that Investor may have, whether specifically granted in this Agreement or any other Transaction Document, or existing
at law, in equity, or by statute, and any and all such rights and remedies may be exercised from time to time and as often and
in such order as Investor may deem expedient.

 

    	 	6	 

    	 

    

 

7.16.
Attorneys’ Fees and Cost of Collection. In the event of any arbitration or action at law or in equity to enforce
or interpret the terms of this Agreement or any of the other Transaction Documents, the parties agree that the prevailing party
(which, for the avoidance of doubt, shall be determined by the body adjudicating the dispute) shall be entitled to an additional
award of the full amount of the reasonable attorneys’ fees, deposition costs, and expenses paid by such prevailing party
in connection with arbitration or litigation without reduction or apportionment based upon the individual claims or defenses giving
rise to the fees and expenses. Nothing herein shall restrict or impair an arbitrator’s or a court’s power to award
fees and expenses for frivolous or bad faith pleading. If (i) the Note is placed in the hands of an attorney for collection or
enforcement prior to commencing arbitration or legal proceedings, or is collected or enforced through any arbitration or legal
proceeding, or Investor otherwise takes action to collect amounts due under the Note or to enforce the provisions of the Note,
or (ii) there occurs any bankruptcy, reorganization, receivership of Company or other proceedings affecting Company’s creditors’
rights and involving a claim under the Note; then Company shall pay the costs incurred by Investor for such collection, enforcement
or action or in connection with such bankruptcy, reorganization, receivership or other proceeding, including, without limitation,
attorneys’ fees, expenses, deposition costs, and disbursements.

 

7.17.
Waiver. No waiver of any provision of this Agreement shall be effective unless it is in the form of a writing signed by
the party granting the waiver. No waiver of any provision or consent to any prohibited action shall constitute a waiver of any
other provision or consent to any other prohibited action, whether or not similar. No waiver or consent shall constitute a continuing
waiver or consent or commit a party to provide a waiver or consent in the future except to the extent specifically set forth in
writing.

 

7.18.
Waiver of Jury Trial. EACH PARTY TO THIS AGREEMENT IRREVOCABLY WAIVES ANY AND ALL RIGHTS SUCH PARTY MAY HAVE TO DEMAND
THAT ANY ACTION, PROCEEDING OR COUNTERCLAIM ARISING OUT OF OR IN ANY WAY RELATED TO THIS AGREEMENT, ANY OTHER TRANSACTION DOCUMENT,
OR THE RELATIONSHIPS OF THE PARTIES HERETO BE TRIED BY JURY. THIS WAIVER EXTENDS TO ANY AND ALL RIGHTS TO DEMAND A TRIAL BY JURY
ARISING UNDER COMMON LAW OR ANY APPLICABLE STATUTE, LAW, RULE OR REGULATION. FURTHER, EACH PARTY HERETO ACKNOWLEDGES THAT SUCH
PARTY IS KNOWINGLY AND VOLUNTARILY WAIVING SUCH PARTY’S RIGHT TO DEMAND TRIAL BY JURY.

 

7.19.
Time is of the Essence. Time is expressly made of the essence with respect to each and every provision of this Agreement
and the other Transaction Documents.

 

7.20.
Voluntary Agreement. Company has carefully read this Agreement and each of the other Transaction Documents and has asked
any questions needed for Company to understand the terms, consequences and binding effect of this Agreement and each of the other
Transaction Documents and fully understand them. Company has had the opportunity to seek the advice of an attorney of Company’s
choosing, or has waived the right to do so, and is executing this Agreement and each of the other Transaction Documents voluntarily
and without any duress or undue influence by Investor or anyone else.

 

[Remainder
of page intentionally left blank; signature page follows]

 

    	 	7	 

    	 

    

 

IN
WITNESS WHEREOF, the undersigned Investor and Company have caused this Agreement to be duly executed as of the date first above
written.

 

	SUBSCRIPTION
    AMOUNT:	 
	 	 
	Principal
    Amount of Note:	$1,347,500.00
	 	 
	Purchase
    Price:	$1,250,000.00

 

	 	INVESTOR:
	 	 	 
	 	Atlas
    Sciences, LLC
	 	 	 
	 	By:
    	Iliad
    Research and Trading, L.P., its Manager
	 	 	 
	 	By:
    	Iliad
    Management, LLC, its General Partner
	 	 	 
	 	By:	Fife
    Trading, Inc., its Manager
	 	 	 
	 	By:	 
	 	 	John
    M. Fife, President
	 	 	 
	 	COMPANY:
	 	 	 
	 	Cancer
    Genetics, Inc.
	 	 	 
	 	By:	 
	 	Name:
    	 
	 	Title:
    	 

 

ATTACHED
EXHIBITS:

 

	

Exhibit
A

	Note
	Exhibit
B 	Flow of Funds
	Exhibit
C 	Secretary’s Certificate
	Exhibit
D 	Arbitration Provisions

 

[Signature Page to
Note Purchase Agreement]

 

    	 	 	 

    	 

    

 

Exhibit
B

 

FLOW
OF FUNDS

 

	ORIGINAL
    PRINCIPAL BALANCE OF THE NOTE:	$1,347,500.00
	 	 	 
	LESS:	 
	 	 	 
	 	ORIGINAL
    ISSUE DISCOUNT:	($87,500.00)
	 	 	 
	 	TRANSACTION
    EXPENSE:	($10,000.00)
	 	 	 
	PURCHASE
    PRICE TO COMPANY:	$1,250,000.00
	 	 	 
	PURCHASE
    PRICE TO BE WIRED AS FOLLOWS:	 
	 	 	 
	 	ILIAD
    RESEARCH AND TRADING, L.P.:	$1,250,000.00
	 	(TO
    REPAY PRIOR INDEBTEDNESS OF COMPANY)	 
	 	 	 
	 	COMPANY:	$0.00

 

	 	ACKNOWLEDGED
    AND AGREED:
	 	 	 
	 	INVESTOR:
	 	 	 
	 	Atlas
    Sciences, LLC
	 	 	 
	 	By:
    	Iliad
    Research and Trading, L.P., its Manager
	 	 	 
	 	By:
    	Iliad
    Management, LLC, its General Partner
	 	 	 
	 	By:	Fife
    Trading, Inc., its Manager
	 	 	 
	 	By:	 
	 	 	John
    M. Fife, President
	 	 	 
	 	COMPANY:
	 	 	 
	 	Cancer
    Genetics, Inc.
	 	 	 
	 	By:	 
	 	Name:
    	 
	 	Title:
    	 

 

    	 	 	 

    	 

    

 

Exhibit
D

 

ARBITRATION
PROVISIONS

 

1.
1. Dispute Resolution. For purposes of this Exhibit D, the term “Claims” means any disputes,
claims, demands, causes of action, requests for injunctive relief, requests for specific performance, liabilities, damages, losses,
or controversies whatsoever arising from, related to, or connected with the transactions contemplated in the Transaction Documents
and any communications between the parties related thereto, including without limitation any claims of mutual mistake, mistake,
fraud, misrepresentation, failure of formation, failure of consideration, promissory estoppel, unconscionability, failure of condition
precedent, rescission, and any statutory claims, tort claims, contract claims, or claims to void, invalidate or terminate the
Agreement (or these Arbitration Provisions (defined below)) or any of the other Transaction Documents. For the avoidance of doubt,
Investor’s pursuit of an injunction or other Claim pursuant to these Arbitration Provisions (as defined below) or a court
will not later prevent Investor under the doctrines of claim preclusion, issue preclusion, res judicata or other similar legal
doctrines from pursuing other Claims in the future. The parties to this Agreement (the “parties”) hereby agree
that the Claims may be arbitrated in one or more Arbitrations pursuant to these Arbitration Provisions. The parties hereby agree
that the arbitration provisions set forth in this Exhibit D (“Arbitration Provisions”) are binding on
each of them. As a result, any attempt to rescind the Agreement (or these Arbitration Provisions) or declare the Agreement (or
these Arbitration Provisions) or any other Transaction Document invalid or unenforceable for any reason is subject to these Arbitration
Provisions. These Arbitration Provisions shall also survive any termination or expiration of the Agreement. Any capitalized term
not defined in these Arbitration Provisions shall have the meaning set forth in the Agreement.

 

2.
Arbitration. Except as otherwise provided herein, all Claims must be submitted to arbitration (“Arbitration”)
to be conducted exclusively in Salt Lake County, Utah and pursuant to the terms set forth in these Arbitration Provisions. Subject
to the arbitration appeal right provided for in Paragraph 5 below (the “Appeal Right”), the parties agree that
the award of the arbitrator rendered pursuant to Paragraph 4 below (the “Arbitration Award”) shall be (a) final
and binding upon the parties, (b) the sole and exclusive remedy between them regarding any Claims, counterclaims, issues, or accountings
presented or pleaded to the arbitrator, and (c) promptly payable in United States dollars free of any tax, deduction or offset
(with respect to monetary awards). Subject to the Appeal Right, any costs or fees, including without limitation attorneys’
fees, incurred in connection with or incident to enforcing the Arbitration Award shall, to the maximum extent permitted by law,
be charged against the party resisting such enforcement. The Arbitration Award shall include default interest (as defined or otherwise
provided for in the Note, “Default Interest”) (with respect to monetary awards) at the rate specified in the
Note for Default Interest both before and after the Arbitration Award. Judgment upon the Arbitration Award will be entered and
enforced by any state or federal court sitting in Salt Lake County, Utah.

 

3.
The Arbitration Act. The parties hereby incorporate herein the provisions and procedures set forth in the Utah Uniform
Arbitration Act, U.C.A. § 78B-11-101 et seq. (as amended or superseded from time to time, the “Arbitration
Act”). Notwithstanding the foregoing, pursuant to, and to the maximum extent permitted by, Section 105 of the Arbitration
Act, in the event of conflict or variation between the terms of these Arbitration Provisions and the provisions of the Arbitration
Act, the terms of these Arbitration Provisions shall control and the parties hereby waive or otherwise agree to vary the effect
of all requirements of the Arbitration Act that may conflict with or vary from these Arbitration Provisions.

 

4.
Arbitration Proceedings. Arbitration between the parties will be subject to the following:

 

4.1
Initiation of Arbitration. Pursuant to Section 110 of the Arbitration Act, the parties agree that a party may initiate
Arbitration by giving written notice to the other party (“Arbitration Notice”) in the same manner that notice
is permitted under Section 7.11 of the Agreement; provided, however, that the Arbitration Notice may not be given by email
or fax. Arbitration will be deemed initiated as of the date that the Arbitration Notice is deemed delivered to such other party
under Section 7.11 of the Agreement (the “Service Date”). After the Service Date, information may be delivered,
and notices may be given, by email or fax pursuant to Section 7.11 of the Agreement or any other method permitted thereunder.
The Arbitration Notice must describe the nature of the controversy, the remedies sought, and the election to commence Arbitration
proceedings. All Claims in the Arbitration Notice must be pleaded consistent with the Utah Rules of Civil Procedure.

 

    	 	 	 

    	 

    

 

4.2
Selection and Payment of Arbitrator.

 

(a)
Within ten (10) calendar days after the Service Date, each party shall select and submit to the other the names of five (5) arbitrators
that are designated as “neutrals” or qualified arbitrators by Utah ADR Services (http://www.utahadrservices.com)
(such five (5) designated persons hereunder are referred to herein as the “Proposed Arbitrators”). For the
avoidance of doubt, each Proposed Arbitrator must be qualified as a “neutral” with Utah ADR Services. Within five
(5) calendar days after each party has submitted the names of the Proposed Arbitrators, the other party must select, by written
notice select one (1) of the Proposed Arbitrators from the other’s list to act as one of the arbitrators for the parties
under these Arbitration Provisions. If a party fails to select one of the other party’s Proposed Arbitrators in writing
within such 5-day period, then the party providing the list may select the arbitrator from its own Proposed Arbitrators by providing
written notice of such selection to the party that has failed to make a selection. If the parties mutually agree, the matter shall
be determined by such two arbitrators. If the parties do not so agree, the two arbitrators selected above shall select a third
“neutral” within five (5) calendar days from a “neutral” who may but need not be a person who appeared
on either parties’ list, or else the Utah ADR Services will be asked to designate a third arbitrator.

 

(b)
If a party fails to submit its Proposed Arbitrators within ten (10) calendar days after the Service Date pursuant to subparagraph
(a) above, then such party shall be deemed to have waived its right to designate an arbitrator and the dispute shall be decided
by the one arbitrator selected pursuant to clause (a) above.

 

(c)
If a Proposed Arbitrator chosen to serve as arbitrator declines or is otherwise unable to serve as arbitrator, then the party
that selected such Proposed Arbitrator may select one (1) of the other three (3) Proposed Arbitrators within three (3) calendar
days of the date the chosen Proposed Arbitrator declines or notifies the parties he or she is unable to serve as arbitrator. If
all three (3) Proposed Arbitrators decline or are otherwise unable to serve as arbitrator, then the arbitrator selection process
shall begin again in accordance with this Paragraph 4.2.

 

(d)
The date that the Proposed Arbitrators selected pursuant to this Paragraph 4.2 agree in writing (including via email) delivered
to both parties to serve as the arbitrator hereunder is referred to herein as the “Arbitration Commencement Date”.
If an arbitrator resigns or is unable to act during the Arbitration, a replacement arbitrator shall be chosen in accordance with
this Paragraph 4.2 to continue the Arbitration. If Utah ADR Services ceases to exist or to provide a list of neutrals and there
is no successor thereto, then the arbitrator shall be selected under the then prevailing rules of the American Arbitration Association.

 

(e)
Subject to Paragraph 4.10 below, the cost of the arbitrator must be paid equally by both parties. Subject to Paragraph 4.10 below,
if one party refuses or fails to pay its portion of the arbitrator fee, then the other party can advance such unpaid amount (subject
to the accrual of Default Interest thereupon), with such amount being added to or subtracted from, as applicable, the Arbitration
Award.

 

4.3
Applicability of Certain Utah Rules. The parties agree that the Arbitration shall be conducted generally in accordance
with the Utah Rules of Civil Procedure and the Utah Rules of Evidence. More specifically, the Utah Rules of Civil Procedure shall
apply, without limitation, to the filing of any pleadings, motions or memoranda, the conducting of discovery, and the taking of
any depositions. The Utah Rules of Evidence shall apply to any hearings, whether telephonic or in person, held by the arbitrator.
Notwithstanding the foregoing, it is the parties’ intent that the incorporation of such rules will in no event supersede
these Arbitration Provisions. In the event of any conflict between the Utah Rules of Civil Procedure or the Utah Rules of Evidence
and these Arbitration Provisions, these Arbitration Provisions shall control.

 

4.4
Answer and Default. An answer and any counterclaims to the Arbitration Notice shall be required to be delivered to the
party initiating the Arbitration within twenty (20) calendar days after the Arbitration Commencement Date. If an answer is not
delivered by the required deadline, the arbitrator must provide written notice to the defaulting party stating that the arbitrator
will enter a default award against such party if such party does not file an answer within five (5) calendar days of receipt of
such notice. If an answer is not filed within the five (5) day extension period, the arbitrator must render a default award, consistent
with the relief requested in the Arbitration Notice, against a party that fails to submit an answer within such time period.

 

    	Arbitration Provisions, Page 2

    	 

    

 

4.5
Related Litigation. The party that delivers the Arbitration Notice to the other party shall have the option to also commence
concurrent legal proceedings with any state or federal court sitting in Salt Lake County, Utah (“Litigation Proceedings”),
subject to the following: (a) the complaint in the Litigation Proceedings is to be substantially similar to the claims set forth
in the Arbitration Notice, provided that an additional cause of action to compel arbitration will also be included therein, (b)
so long as the other party files an answer to the complaint in the Litigation Proceedings and an answer to the Arbitration Notice,
the Litigation Proceedings will be stayed pending an Arbitration Award (or Appeal Panel Award (defined below), as applicable)
hereunder, (c) if the other party fails to file an answer in the Litigation Proceedings or an answer in the Arbitration proceedings,
then the party initiating Arbitration shall be entitled to a default judgment consistent with the relief requested, to be entered
in the Litigation Proceedings, and (d) any legal or procedural issue arising under the Arbitration Act that requires a decision
of a court of competent jurisdiction may be determined in the Litigation Proceedings. Any award of the arbitrator (or of the Appeal
Panel (defined below)) may be entered in such Litigation Proceedings pursuant to the Arbitration Act.

 

4.6
Discovery. Pursuant to Section 118(8) of the Arbitration Act, the parties agree that discovery shall be conducted as follows:

 

(a)
Written discovery will only be allowed if the likely benefits of the proposed written discovery outweigh the burden or expense
thereof, and the written discovery sought is likely to reveal information that will satisfy a specific element of a claim or defense
already pleaded in the Arbitration. The party seeking written discovery shall always have the burden of showing that all of the
standards and limitations set forth in these Arbitration Provisions are satisfied. The scope of discovery in the Arbitration proceedings
shall also be limited as follows:

 

(i)
To facts directly connected with the transactions contemplated by the Agreement.

 

(ii)
To facts and information that cannot be obtained from another source or in another manner that is more convenient, less burdensome
or less expensive than in the manner requested.

 

(b)
No party shall be allowed (i) more than fifteen (15) interrogatories (including discrete subparts), (ii) more than fifteen (15)
requests for admission (including discrete subparts), (iii) more than ten (10) document requests (including discrete subparts),
or (iv) more than three (3) depositions (excluding expert depositions) for a maximum of seven (7) hours per deposition. The costs
associated with depositions will be borne by the party taking the deposition. The party defending the deposition will submit a
notice to the party taking the deposition of the estimated attorneys’ fees that such party expects to incur in connection
with defending the deposition. If the party defending the deposition fails to submit an estimate of attorneys’ fees within
five (5) calendar days of its receipt of a deposition notice, then such party shall be deemed to have waived its right to the
estimated attorneys’ fees. The party taking the deposition must pay the party defending the deposition the estimated attorneys’
fees prior to taking the deposition, unless such obligation is deemed to be waived as set forth in the immediately preceding sentence.
If the party taking the deposition believes that the estimated attorneys’ fees are unreasonable, such party may submit the
issue to the arbitrator for a decision. All depositions requested by the Company will be taken in Utah, and all depositions requested
by the Investor will be taken in New Jersey.

 

(c)
All discovery requests (including document production requests included in deposition notices) must be submitted in writing to
the arbitrator and the other party. The party submitting the written discovery requests must include with such discovery requests
a detailed explanation of how the proposed discovery requests satisfy the requirements of these Arbitration Provisions and the
Utah Rules of Civil Procedure. The receiving party will then be allowed, within five (5) calendar days of receiving the proposed
discovery requests, to submit to the arbitrator an estimate of the attorneys’ fees and costs associated with responding
to such written discovery requests and a written challenge to each applicable discovery request. After receipt of an estimate
of attorneys’ fees and costs and/or challenge(s) to one or more discovery requests, consistent with subparagraph (c) above,
the arbitrator will within three (3) calendar days make a finding as to the likely attorneys’ fees and costs associated
with responding to the discovery requests and issue an order that (i) requires the requesting party to prepay the attorneys’
fees and costs associated with responding to the discovery requests, and (ii) requires the responding party to respond to the
discovery requests as limited by the arbitrator within twenty-five (25) calendar days of the arbitrator’s finding with respect
to such discovery requests. If a party entitled to submit an estimate of attorneys’ fees and costs and/or a challenge to
discovery requests fails to do so within such 5-day period, the arbitrator will make a finding that (A) there are no attorneys’
fees or costs associated with responding to such discovery requests, and (B) the responding party must respond to such discovery
requests (as may be limited by the arbitrator) within twenty-five (25) calendar days of the arbitrator’s finding with respect
to such discovery requests. Any party submitting any written discovery requests, including without limitation interrogatories,
requests for production subpoenas to a party or a third party, or requests for admissions, must prepay the estimated attorneys’
fees and costs, before the responding party has any obligation to produce or respond to the same, unless such obligation is deemed
waived as set forth above.

 

    	Arbitration Provisions, Page 3

    	 

    

 

(d)
In order to allow a written discovery request, the arbitrator must find that the discovery request satisfies the standards set
forth in these Arbitration Provisions and the Utah Rules of Civil Procedure. The arbitrator must strictly enforce these standards.
If a discovery request does not satisfy any of the standards set forth in these Arbitration Provisions or the Utah Rules of Civil
Procedure, the arbitrator may modify such discovery request to satisfy the applicable standards, or strike such discovery request
in whole or in part.

 

(e)
Each party may submit expert reports (and rebuttals thereto), provided that such reports must be submitted within sixty (60) days
of the Arbitration Commencement Date. Each party will be allowed a maximum of two (2) experts. Expert reports must contain the
following: (i) a complete statement of all opinions the expert will offer at trial and the basis and reasons for them; (ii) the
expert’s name and qualifications, including a list of all the expert’s publications within the preceding ten (10)
years, and a list of any other cases in which the expert has testified at trial or in a deposition or prepared a report within
the preceding ten (10) years; and (iii) the compensation to be paid for the expert’s report and testimony. The parties are
entitled to depose any other party’s expert witness one (1) time for no more than seven (7) hours. An expert may not testify
in a party’s case-in-chief concerning any matter not fairly disclosed in the expert report.

 

4.6
Dispositive Motions. Each party shall have the right to submit dispositive motions pursuant Rule 12 or Rule 56 of the Utah
Rules of Civil Procedure (a “Dispositive Motion”). The party submitting the Dispositive Motion may, but is
not required to, deliver to the arbitrator and to the other party a memorandum in support (the “Memorandum in Support”)
of the Dispositive Motion. Within seven (7) calendar days of delivery of the Memorandum in Support, the other party shall deliver
to the arbitrator and to the other party a memorandum in opposition to the Memorandum in Support (the “Memorandum in
Opposition”). Within seven (7) calendar days of delivery of the Memorandum in Opposition, as applicable, the party that
submitted the Memorandum in Support shall deliver to the arbitrator and to the other party a reply memorandum to the Memorandum
in Opposition (“Reply Memorandum”). If the applicable party shall fail to deliver the Memorandum in Opposition
as required above, or if the other party fails to deliver the Reply Memorandum as required above, then the applicable party shall
lose its right to so deliver the same, and the Dispositive Motion shall proceed regardless.

 

4.7
Confidentiality. All information disclosed by either party (or such party’s agents) during the Arbitration process
(including without limitation information disclosed during the discovery process or any Appeal (defined below)) shall be considered
confidential in nature. Each party agrees not to disclose any confidential information received from the other party (or its agents)
during the Arbitration process (including without limitation during the discovery process or any Appeal) unless (a) prior to or
after the time of disclosure such information becomes public knowledge or part of the public domain, not as a result of any inaction
or action of the receiving party or its agents, (b) such information is required by a court order, subpoena or similar legal duress
to be disclosed if such receiving party has notified the other party thereof in writing and given it a reasonable opportunity
to obtain a protective order from a court of competent jurisdiction prior to disclosure, or (c) such information is disclosed
to the receiving party’s agents, representatives and legal counsel on a need to know basis who each agree in writing not
to disclose such information to any third party. Pursuant to Section 118(5) of the Arbitration Act, the arbitrator is hereby authorized
and directed to issue a protective order to prevent the disclosure of privileged information and confidential information upon
the written request of either party.

 

4.8
Authorization; Timing; Scheduling Order. Subject to all other portions of these Arbitration Provisions, the parties hereby
authorize and direct the arbitrator to take such actions and make such rulings as may be necessary to carry out the parties’
intent for the Arbitration proceedings to be efficient and expeditious. Pursuant to Section 120 of the Arbitration Act, the parties
hereby agree that an Arbitration Award must be made within one hundred twenty (120) calendar days after the Arbitration Commencement
Date. The arbitrator is hereby authorized and directed to hold a scheduling conference within ten (10) calendar days after the
Arbitration Commencement Date in order to establish a scheduling order with various binding deadlines for discovery, expert testimony,
and the submission of documents by the parties to enable the arbitrator to render a decision prior to the end of such 120-day
period.

 

    	Arbitration Provisions, Page 4

    	 

    

 

4.9
Relief. The arbitrator shall have the right to award or include in the Arbitration Award (or in a preliminary ruling) any
relief which the arbitrator deems proper under the circumstances, including, without limitation, specific performance and injunctive
relief, provided that the arbitrator may not award exemplary or punitive damages.

 

4.10
Fees and Costs. As part of the Arbitration Award, the arbitrator is hereby directed to require the losing party to reimburse
the prevailing party for all reasonable attorneys’ fees, arbitrator costs and fees, deposition costs, other discovery costs,
and other expenses, costs or fees paid or otherwise incurred by the prevailing party in connection with the Arbitration. For the
avoidance of doubt, the arbitrator must choose one party as the prevailing party.

 

5.
Arbitration Appeal.

 

5.1
Initiation of Appeal. Following the entry of the Arbitration Award, either party (the “Appellant”) shall
have a period of thirty (30) calendar days in which to notify the other party (the “Appellee”), in writing,
that the Appellant elects to appeal (the “Appeal”) the Arbitration Award (such notice, an “Appeal
Notice”) to a panel of arbitrators as provided in Paragraph 5.2 below. The date the Appellant delivers an Appeal Notice
to the Appellee is referred to herein as the “Appeal Date”. The Appeal Notice must be delivered to the Appellee
in accordance with the provisions of Paragraph 4.1 above with respect to delivery of an Arbitration Notice. In addition, together
with delivery of the Appeal Notice to the Appellee, the Appellant must also pay for (and provide proof of such payment to the
Appellee together with delivery of the Appeal Notice) a bond in the amount of 110% of the sum the Appellant owes to the Appellee
as a result of the Arbitration Award the Appellant is appealing. In the event an Appellant delivers an Appeal Notice to the Appellee
(together with proof of payment of the applicable bond) in compliance with the provisions of this Paragraph 5.1, the Appeal will
occur as a matter of right and, except as specifically set forth herein, will not be further conditioned. In the event a party
does not deliver an Appeal Notice (along with proof of payment of the applicable bond) to the other party within the deadline
prescribed in this Paragraph 5.1, such party shall lose its right to appeal the Arbitration Award. If no party delivers an Appeal
Notice (along with proof of payment of the applicable bond) to the other party within the deadline described in this Paragraph
5.1, the Arbitration Award shall be final. The parties acknowledge and agree that any Appeal shall be deemed part of the parties’
agreement to arbitrate for purposes of these Arbitration Provisions and the Arbitration Act.

 

5.2
Selection and Payment of Appeal Panel. In the event an Appellant delivers an Appeal Notice to the Appellee (together with
proof of payment of the applicable bond) in compliance with the provisions of Paragraph 5.1 above, the Appeal will be heard by
a three (3) person arbitration panel (the “Appeal Panel”).

 

(a)
Within ten (10) calendar days after the Appeal Date, each party shall select and submit to the other the names of five (5) arbitrators
that are designated as “neutrals” or qualified arbitrators by Utah ADR Services (http://www.utahadrservices.com)
(such five (5) designated persons hereunder are referred to herein as the “Proposed Appeal Arbitrators”). For
the avoidance of doubt, each Proposed Appeal Arbitrator must be qualified as a “neutral” with Utah ADR Services, and
shall not be the arbitrator who rendered the Arbitration Award being appealed (the “Original Arbitrator”).
Within five (5) calendar days after each party has submitted to the Appellant the names of the Proposed Appeal Arbitrators, the
other party must select, by written notice to the Appellee, one (1) of the other party’s Proposed Appeal Arbitrators to
act as a member of the Appeal Panel. If a party fails to select a Proposed Appeal Arbitrators in writing within such 5-day period,
then the party providing the list may select the arbitrator from its own Proposed Arbitrators by providing written notice of such
selection to the party that has failed to make a selection. The two Appeal Arbitrators selected above shall select a third “neutral”
within five (5) calendar days from a “neutral” who may but need not be a person who appeared on either parties’
list, or else the Utah ADR Services will be asked to designate a third Appeal Arbitrator.

 

(b)
If a party fails to submit its Proposed Appeal Arbitrators within ten (10) calendar days after the Service Date pursuant to subparagraph
(a) above, then such party shall be deemed to have waived its right to designate an Appeals Arbitrator and the appeal shall be
decided by the two Appeals Arbitrators selected pursuant to clause (a) above, plus one additional neutral Appeals Arbitrator selected
by them.

 

    	Arbitration Provisions, Page 5

    	 

    

 

(c)
If a selected Proposed Appeal Arbitrator declines or is otherwise unable to serve, then the party that selected such Proposed
Appeal Arbitrator may select one (1) of the other five (5) designated Proposed Appeal Arbitrators within three (3) calendar days
of the date a chosen Proposed Appeal Arbitrator declines or notifies the parties he or she is unable to serve as an arbitrator.
If at least three (3) of the five (5) designated Proposed Appeal Arbitrators decline or are otherwise unable to serve, then the
Proposed Appeal Arbitrator selection process shall begin again in accordance with this Paragraph 5.2; provided, however,
that any Proposed Appeal Arbitrators who have already agreed to serve shall remain on the Appeal Panel.

 

(d)
The date that all three (3) Proposed Appeal Arbitrators selected pursuant to this Paragraph 5.2 agree in writing (including via
email) delivered to both the Appellant and the Appellee to serve as members of the Appeal Panel hereunder is referred to herein
as the “Appeal Commencement Date”. No later than five (5) calendar days after the Appeal Commencement Date,
the Appellee shall designate in writing (including via email) to the Appellant and the Appeal Panel the name of one (1) of the
three (3) members of the Appeal Panel to serve as the lead arbitrator in the Appeal proceedings. Each member of the Appeal Panel
shall be deemed an arbitrator for purposes of these Arbitration Provisions and the Arbitration Act, provided that, in conducting
the Appeal, the Appeal Panel may only act or make determinations upon the approval or vote of no less than the majority vote of
its members, as announced or communicated by the lead arbitrator on the Appeal Panel. If
an arbitrator on the Appeal Panel ceases or is unable to act during the Appeal proceedings, a replacement arbitrator shall be
chosen in accordance with Paragraph 5.2 above to continue the Appeal as a member of the Appeal Panel. If Utah ADR Services
ceases to exist or to provide a list of neutrals, then the arbitrators for the Appeal Panel shall be selected under the then prevailing
rules of the American Arbitration Association.

 

(d)
Subject to Paragraph 5.7 below, the cost of the Appeal Panel must be paid entirely by the Appellant.

 

5.3
Appeal Procedure. The Appeal will be deemed an appeal of the entire Arbitration Award. In conducting the Appeal, the Appeal
Panel shall conduct a de novo review of all Claims described or otherwise set forth in the Arbitration Notice. Subject to the
foregoing and all other provisions of this Paragraph 5, the Appeal Panel shall conduct the Appeal in a manner the Appeal Panel
considers appropriate for a fair and expeditious disposition of the Appeal, may hold one or more hearings and permit oral argument,
and may review all previous evidence and discovery, together with all briefs, pleadings and other documents filed with the Original
Arbitrator (as well as any documents filed with the Appeal Panel pursuant to Paragraph 5.4(a) below). Notwithstanding the foregoing,
in connection with the Appeal, the Appeal Panel shall not permit the parties to conduct any additional discovery or raise any
new Claims to be arbitrated, shall not permit new witnesses or affidavits, and shall not base any of its findings or determinations
on the Original Arbitrator’s findings or the Arbitration Award.

 

5.4
Timing.

 

(a)
Within seven (7) calendar days of the Appeal Commencement Date, the Appellant (i) shall deliver or cause to be delivered to the
Appeal Panel copies of the Appeal Notice, all discovery conducted in connection with the Arbitration, and all briefs, pleadings
and other documents filed with the Original Arbitrator (which material Appellee shall have the right to review and supplement
if necessary), and (ii) may, but is not required to, deliver to the Appeal Panel and to the Appellee a Memorandum in Support of
the Appellant’s arguments concerning or position with respect to all Claims, counterclaims, issues, or accountings presented
or pleaded in the Arbitration. Within seven (7) calendar days of the Appellant’s delivery of the Memorandum in Support,
as applicable, the Appellee shall deliver to the Appeal Panel and to the Appellant a Memorandum in Opposition to the Memorandum
in Support. Within seven (7) calendar days of the Appellee’s delivery of the Memorandum in Opposition, as applicable, the
Appellant shall deliver to the Appeal Panel and to the Appellee a Reply Memorandum to the Memorandum in Opposition. If the Appellant
shall fail to substantially comply with the requirements of clause (i) of this subparagraph (a), the Appellant shall lose its
right to appeal the Arbitration Award, and the Arbitration Award shall be final. If the Appellee shall fail to deliver the Memorandum
in Opposition as required above, or if the Appellant shall fail to deliver the Reply Memorandum as required above, then the Appellee
or the Appellant, as the case may be, shall lose its right to so deliver the same, and the Appeal shall proceed regardless.

 

(b)
Subject to subparagraph (a) above, the parties hereby agree that the Appeal must be heard by the Appeal Panel within thirty (30)
calendar days of the Appeal Commencement Date, and that the Appeal Panel must render its decision within thirty (30) calendar
days after the Appeal is heard (and in no event later than sixty (60) calendar days after the Appeal Commencement Date).

 

    	Arbitration Provisions, Page 6

    	 

    

 

5.5
Appeal Panel Award. The Appeal Panel shall issue its decision (the “Appeal Panel Award”) through the
lead arbitrator on the Appeal Panel. Notwithstanding any other provision contained herein, the Appeal Panel Award shall (a) supersede
in its entirety and make of no further force or effect the Arbitration Award (provided that any protective orders issued by the
Original Arbitrator shall remain in full force and effect), (b) be final and binding upon the parties, with no further rights
of appeal, (c) be the sole and exclusive remedy between the parties regarding any Claims, counterclaims, issues, or accountings
presented or pleaded in the Arbitration, and (d) be promptly payable in United States dollars free of any tax, deduction or offset
(with respect to monetary awards). Any costs or fees, including without limitation attorneys’ fees, incurred in connection
with or incident to enforcing the Appeal Panel Award shall, to the maximum extent permitted by law, be charged against the party
resisting such enforcement. The Appeal Panel Award shall include Default Interest (with respect to monetary awards) at the rate
specified in the Note for Default Interest both before and after the Arbitration Award. Judgment upon the Appeal Panel Award will
be entered and enforced by a state or federal court sitting in Salt Lake County, Utah.

 

5.6
Relief. The Appeal Panel shall have the right to award or include in the Appeal Panel Award any relief which the Appeal
Panel deems proper under the circumstances, including, without limitation, specific performance and injunctive relief, provided
that the Appeal Panel may not award exemplary or punitive damages.

 

5.7
Fees and Costs. As part of the Appeal Panel Award, the Appeal Panel is hereby directed to require the losing party reimburse
the prevailing party the reasonable attorneys’ fees, arbitrator and Appeal Panel costs and fees, deposition costs, other
discovery costs, and other expenses, costs or fees paid or otherwise incurred by the prevailing party in connection with the Arbitration
(including without limitation in connection with the Appeal). For the avoidance of doubt, the Appeal Panel must choose one party
as the prevailing party.

 

6.
Miscellaneous.

 

6.1
Severability. If any part of these Arbitration Provisions is found to violate or be illegal under applicable law, then
such provision shall be modified to the minimum extent necessary to make such provision enforceable under applicable law, and
the remainder of the Arbitration Provisions shall remain unaffected and in full force and effect.

 

6.2
Governing Law. These Arbitration Provisions shall be governed by the laws of the State of Utah without regard to the conflict
of laws principles therein.

 

6.3
Interpretation. The headings of these Arbitration Provisions are for convenience of reference only and shall not form part
of, or affect the interpretation of, these Arbitration Provisions.

 

6.4
Waiver. No waiver of any provision of these Arbitration Provisions shall be effective unless it is in the form of a writing
signed by the party granting the waiver.

 

6.5
Time is of the Essence. Time is expressly made of the essence with respect to each and every provision of these Arbitration
Provisions.

 

[Remainder
of page intentionally left blank]

 

    	Arbitration Provisions, Page 7Execution
Document

 

SETTLEMENT
AGREEMENT

 

This
Settlement Agreement (this “Agreement”) is entered into as of October 21, 2019 by and between NovellusDx Ltd.,
a company formed under the laws of the State of Israel (“Lender”), and Cancer Genetics, Inc., a Delaware corporation
(“Borrower”).

 

RECITALS

 

A.
 Borrower and Lender are parties to that certain Credit Agreement dated as of September 18, 2018 (the “Credit Agreement”)
and Promissory Note dated the same date (the “Note”). There is due under the Note the principal sum of $1,500,000,
plus interest accrued thereon (the amount currently due referred to as the “Outstanding Balance”). Borrower
and Lender also entered into an Agreement and Plan of Merger dated September 18, 2018, which was previously terminated (the “Merger
Agreement”), and a Registration Rights Agreement. The Credit Agreement (as amended hereby), the Note (as amended hereby),
the Merger Agreement, the Registration Rights Agreement and all other documents and agreements entered into in connection therewith
or related thereto (other than, for the elimination of doubt, this Agreement), are referred to as the “Transaction Documents”.

 

B.
 On July 15, 2019, Borrower entered into a secured creditor asset purchase agreement (the “BioPharma Agreement”)
with Partners for Growth IV, L.P., Interpace Diagnostics Group, Inc. (“IDXG”) and a newly-formed subsidiary
of IDXG, Interpace BioPharma, Inc. (“Buyer”). Pursuant to the BioPharma Agreement, Buyer issued to the Borrower
a promissory note in the initial principal sum of $7,692,300, subject to certain reductions as described in the Borrower’s
filings with the SEC (the “Excess Consideration Note”). The Excess Consideration Note will mature on the earlier
of the date (i) five (5) business days after the consummation of an investment by Ampersand Capital Partners or any of its affiliates
into IDXG or Buyer, following IDXG receiving the approval of its shareholders of the issuance of shares of its common stock in
connection therewith and (ii) July 15, 2022.

 

C.
 As a result of the transactions described in B above, Borrower and Lender believe they will be able to, and have agreed
to settle all claims between them and terminate the Credit Agreement and Note as set forth in this Agreement, and exchange mutual
releases subject to the terms, conditions and understandings set forth herein.

 

D.
 Capitalized terms used herein but not defined herein shall have the respective meanings ascribed thereto in the Credit Agreement.

 

AGREEMENT

 

NOW,
THEREFORE, for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties, intending
to be legally bound hereby, agree as follows:

 

1.
 Initial Payment. On the date hereof, Borrower is paying to Lender $100,000 against the principal balance of the Note
by wire transfer to an account designated in writing by Lender on or prior to the date hereof.

 

    	 

    	 

    

 

2.
 Standstill. For a period beginning as of the date hereof and ending on February 28, 2020 (the “Standstill
Period”), Lender will not demand payment of any portion of the Note in cash (the “Standstill”). Notwithstanding
the foregoing, the Standstill shall immediately and automatically terminate five (5) business days after Borrower receives one
or more payments aggregating at least $5.0 million with respect to the Excess Consideration Note if the payment required under
Section 3(a) below has not yet been made.

 

3.
 Future Payments. In exchange for the discharge and forgiveness of all amounts due under the Credit Agreement and
the Note, and the releases contemplated hereunder, Borrower agrees to make the following payments to Lender:

 

	 	a)	On the fifth (5th)
    business day after Borrower’s receipt of one or more payments aggregating at least five million dollars ($5,000,000)
    from Buyer on Buyer’s obligations under the Excess Consideration Note, (such 5th day, the “One Million
    Payment Date”), Borrower shall pay Lender the sum of one million dollars ($1,000,000) (the “One Million
    Payment”) in cash by wire transfer of immediately available funds to an account designated in writing by Lender.
	 	 	 
	 	b)	On the One Million
    Payment Date and payment by Borrower and receipt by Lender of the One Million Payment, the Credit Agreement and the Note will
    be deemed modified as set forth herein and as provided in Exhibit A annexed hereto such that, in lieu of all obligations
    currently and then existing under the Credit Agreement and the Note, Borrower’s sole obligation shall be that commencing
    one month after the One Million Payment Date and receipt by Lender of the One Million Payment from the Borrower, on each of
    the first nine monthly anniversaries of the One Million Payment Date, Borrower shall pay Lender the sum of Fifty Thousand
    Dollars ($50,000) (or an aggregate of Four Hundred Fifty Thousand Dollars ($450,000) to be paid pursuant to this clause (b)
    and under the Credit Agreement and Note as modified hereunder), in each case in cash by wire transfer of immediately available
    funds to an account designated in writing by Lender.

 

4.
 Amendment and Cancellation of Credit Agreement and Note.

 

	 	(a)	The parties agree that immediately
    upon the payment by Borrower of the One Million Payment, the Credit Agreement and Note shall be amended effective immediately
    upon such payment with no further action by the parties being required (i) so that the total amount due thereunder shall at
    such time be reduced to $450,000, and (ii) as set forth in Exhibit A.
	 	 	 
	 	(b)	The parties agree
    that immediately upon the final payment by Borrower pursuant to Section 3(b) above, the Credit Agreement and Note shall be
    terminated, and all of Borrower’s obligations thereunder shall be deemed discharged and forgiven. Lender shall physically
    deliver the original Note to the Borrower marked “Cancelled” promptly following its receipt of the last such payment;
    provided that the failure of Lender to physically deliver such original Note shall not affect the termination and discharge
    of the Credit Agreement and Note as provided herein, nor the effectiveness of the releases contained in Section 5 below, nor
    shall such failure modify, amend, waive or otherwise affect any of Borrower’s obligations hereunder.

 

    	-2-

    	 

    

 

5.
 General Releases.

 

(a)
 Lender’s Release of Borrower. On the One Million Payment Date, upon Borrower making the One Million Payment,
Lender, on behalf of itself, its predecessors, successors, affiliates, principals and assigns, (collectively, the “Lender
Releasing Parties”), shall be deemed to have fully and irrevocably released and discharged Borrower together with its
predecessors, successors, affiliates, and assigns, its direct and indirect subsidiary companies and companies under common control
with any of the foregoing, and its past, present, and future officers, directors, managers, shareholders, interest holders, attorneys,
agents, employees, representatives, and any person acting by, through, under, or in concert with them (collectively, the “Borrower
Released Parties”) from any and all claims, rights, demands, actions, suits, causes of action, grievances, liabilities,
obligations, controversies, damages, costs, expenses, losses, and debts, of any nature whatsoever, known or unknown, contingent
or definitive, direct or indirect, conditional or unconditional, that the Lender Releasing Parties had, have, or may have against
the Borrower Released Parties, including but not limited to claims in respect of any breach or alleged breach by Borrower under
the Credit Agreement, the Note, the Registration Rights Agreement, the Merger Agreement or the other Transaction Documents, in
each case occurring prior to the date hereof, (the “Lender Released Claims”). The Lender Released Claims include
those of which the Lender Releasing Parties are presently unaware or which the Lender Releasing Parties do not presently expect
to exist and which, if known to the Lender Releasing Parties, would materially affect their release of the Borrower Released Parties.

 

(b)
 Borrower’s Release of Lender. On the One Million Payment Date, upon Borrower making the One Million Payment,
Borrower, on behalf of itself, its predecessors, successors, affiliates, principals and assigns (collectively, the “Borrower
Releasing Parties”), shall be deemed to have fully and irrevocably released and discharged Lender, together with its
predecessors, successors, affiliates, and assigns, its direct and indirect subsidiary companies and companies under common control
with any of the foregoing, and its past, present, and future officers, directors, managers, shareholders, interest holders, attorneys,
agents, employees, representatives, and any person acting by, through, under, or in concert with them (collectively, the “Lender
Released Parties”) from any and all claims, rights, demands, actions, suits, causes of action, grievances, liabilities,
obligations, controversies, damages, costs, expenses, losses, and debts, of any nature whatsoever, known or unknown, contingent
or definitive, direct or indirect, conditional or unconditional, that the Borrower Releasing Parties had, have, or may have against
the Lender Released Parties, including but not limited to claims in respect of any breach or alleged breach by Lender under the
Credit Agreement, the Note, the Registration Rights Agreement, the Merger Agreement or the other Transaction Documents, in each
case occurring prior to the date hereof (the “Borrower Released Claims”). The Borrower Released Claims include
those of which the Borrower Releasing Parties are presently unaware or which the Borrower Releasing Parties do not presently expect
to exist and which, if known to the Borrower Releasing Parties, would materially affect their release of the Lender Released Parties.

 

    	-3-

    	 

    

 

(c)
 No Release of Claims Relating to this Agreement. Notwithstanding anything in this Agreement to the contrary, the
releases set forth in Sections 5(a) and 5(b) above shall not apply to Borrower’s obligation to make the payments aggregating
$450,000 required under Section 3(b) hereof and the amended Credit Agreement and Note or any of the Parties’ other obligations
under this Agreement.

 

(d)
 Reaffirmation Document. Immediately following Lender’s receipt of the final payment contemplated by Section
3(b) hereof and under the amended Credit Agreement and Note, Borrower and Lender shall exchange a form of mutual release reaffirming
the releases contemplated by this Section 5 as of the One Million Payment Date, but without the exceptions set forth in Section
5(c).

 

6.
 Optional Conversion Upon Payment Default.

 

(a)
 In connection with the amendments to the Credit Agreement and Note effected hereby, if Borrower fails to make any payment
against the $450,000 balance required pursuant to Section 3(b) hereof and the amended Credit Agreement and Note, within five (5)
business days of any payment due date, then, at any time thereafter if the amount is still unpaid, Lender may deliver to Borrower
written notice of Lender’s election to convert (the “Conversion Notice”) all, but not less than all,
of the amounts then owing and unpaid pursuant the amended Credit Agreement and Note into a number of shares (“Conversion
Shares”) of Borrower’s Common Stock, equal to the aggregate amount due and unpaid thereunder divided by
$ 0.15 (15 cents). The date on which Lender delivers a Conversion Notice to Borrower is the “Conversion Date”.
The Conversion Notice shall be in the form reasonably acceptable to Borrower and shall also attach a reaffirmation of the representations
set forth in Section 7.

 

(b)
 Lender agrees that any issuance to it of Conversion Shares shall be made in compliance with all applicable rules of Nasdaq,
and that it shall sell any Conversion Shares only in accordance with all applicable federal and state securities laws.

 

(c)
 Lender and Borrower agree that for the purposes of Rule 144 (“Rule 144”) promulgated under the Securities
Act of 1933, as amended (the “Securities Act”), the holding period of the Note and any Conversion Shares commenced
on September 18, 2018, which date is the date that the Note was originally issued to, and paid for by, Lender. Borrower agrees
not to take a position contrary to this Section 6(c) in any document, statement, setting, or situation. Borrower agrees to take
all action necessary to issue the Conversion Shares without restriction, and not containing any restrictive legend without the
need for any action by Lender; and Borrower shall cause its counsel to promptly provide any opinion required by Borrower’s
transfer agent such that the transfer agent may issue the Conversion Shares to Lender without restriction, restrictive legends
or stop orders. Additionally, Borrower shall instruct its transfer agent that it may accept such an opinion from counsel to Lender,
which opinion shall not be subject to Borrower’s review, consent or approval. In furtherance thereof, counsel to Lender
may, in its sole discretion, provide an opinion that: (a) the Conversion Shares may be resold pursuant to Rule 144 without volume
or manner-of-sale restrictions or current public information requirements; and (b) the transactions contemplated hereby and all
other documents associated with this transaction comport with the requirements of Section 3(a)(9) of the Securities Act. Borrower
represents that it is not subject to Rule 144(i). Lender agrees to provide counsel with a customary Rule 144 representation letter
in connection with a request that it issue any opinion hereunder. The Conversion Shares if issued in accordance with the terms
hereof and the amended Credit Agreement and Note will be issued in substitution of and exchange for and not in satisfaction of
the Note. Neither the Note as amended hereby nor the Conversion Shares will constitute a novation or satisfaction and accord of
the Note.

 

    	-4-

    	 

    

 

(d)
 Borrower represents and warrants to Lender that the Conversion Shares have been duly authorized and, if and when issued
to Lender in accordance with the terms hereof, shall be validly issued, fully paid and nonassessable. Borrower shall use reasonable
efforts to satisfy the current public information requirement under Rule 144(c) until the earlier of (i) the date on which Borrower
has paid to Lender all amounts required by Section 3(b) and (ii) the date on which Lender shall have sold all Conversion Shares.
Borrower acknowledges and agrees that so long as Lender does not own beneficially more than 9.99% of the issued and outstanding
Borrower Common Stock (the “Maximum Percentage”), Lender is not and will not be an “affiliate”
of Borrower (as defined under Rule 144). Promptly, and in any event on or prior to the second (2nd) business day immediately
following Lender’s delivery of a Conversion Notice and the opinion contemplated by Section (c) above, and provided that
at such time Lender does not beneficially own Borrower Common Stock in excess of the Maximum Percentage, Borrower shall cause)
its transfer agent to issue such Conversion Shares free and clear of all restrictive legends and stop orders as directed by Lender
or its applicable agents. Without the prior written consent of Lender, neither Borrower nor any of its officers, directors, agents
or representatives shall provide Lender with any material non-public information regarding Borrower. If, in contravention of the
immediately preceding sentence, Borrower provides Lender with any such material non-public information, Borrower shall promptly,
and in any event within four (4) business days, publicly disclose such information in any manner compliant with Regulation FD.

 

7.
 Representations, Warranties, and Agreements of Lender. As a condition precedent to the issuance of any Conversion
Shares, Lender shall represent and warrant to, and covenant and agree with, Borrower as follows, in the Conversion Notice:

 

(a)
 Acquisition of Shares Entirely for Own Account. The Conversion Shares are being or will be issued to Lender in reliance
upon Lender’s representations to Borrower that the Conversion Shares will be acquired by Lender for investment for Lender’s
own account, not as a nominee or agent, and not with a view to the resale or distribution of any part thereof, other than in compliance
with all applicable federal and state securities laws.

 

(b)
 Access to Information. Lender has had an opportunity to ask Borrower and its officer’s questions and receive
answers regarding Borrower’s business, management, and financial affairs, and the terms and conditions of the purchase of
the Conversion Shares.

 

(c)
 Restricted Securities. Lender understands that the Conversion Shares have not been, and will not be, registered under
the Securities Act. Lender understands that the Conversion Shares are “restricted securities” under applicable U.S.
federal and state securities laws and that, pursuant to these laws, Lender must hold the Conversion Shares indefinitely unless
the Conversion Shares are registered with the Securities and Exchange Commission and qualified by state authorities, or an exemption
from such registration and qualification requirements is available. Lender acknowledges that Borrower has no obligation to register
or qualify the Conversion Shares for resale. Lender does not have a short position with respect to any Borrower Common Stock.

 

    	-5-

    	 

    

 

(d)
 Accredited Investor. Lender is and will continue to be an “accredited investor” as defined in Rule 501(a)
of Regulation D promulgated under the Securities Act.

 

(e)
 Beneficial Ownership. Upon issuance of the Conversion Shares, Lender will beneficially own less than 9.9% of Borrower’s
Common Stock.

 

8.
 Warranties. Each Party represents and warrants that:

 

(a)
 The Party has had the opportunity to consult an attorney with respect to the terms, conditions, and effect of this Agreement;

 

(b)
 The Party has fully investigated all the facts and circumstances surrounding the terms of this Agreement and is satisfied
that it is fully informed of the terms, conditions, and effect of this Agreement;

 

(c)
 The Party is relying on its own judgment in deciding to execute this Agreement and has not been influenced by any statement
or representation made by or on behalf of the other Party to this Agreement;

 

(d)
 The Party has not assigned or transferred any of the claims, demands, actions, or rights being released by such Party pursuant
to this Agreement and covenants not to sue or prosecute, institute or cooperate in the institution, commencement, filing or prosecution
of any suit or proceeding in any forum based upon or related to any claim being released herein; and

 

(e)
 The Party has full and complete authority to enter into this Agreement, to release the claims such Party will be releasing,
and to execute this Agreement. Such Party’s entering into this Agreement and performing its obligations hereunder has been
duly authorized by all corporate and other required action on the part of such Party’s board of directors or other applicable
governing body, and this Agreement, when duly executed and delivered by such Party, shall be a valid and legally binding obligation
of such Party, enforceable against such Party in accordance with its terms.

 

9.
 Governing Law; Venue. This Agreement shall be governed by and interpreted in accordance with the laws of the State
of Delaware without regard to the principles of conflict of laws of such state that would cause the application of the laws of
any other jurisdiction. Each of the parties hereto hereby (a) agrees that any claim, suit, action or other proceeding, directly
or indirectly, arising out of, under or relating to this Agreement, will be heard and determined in the Chancery Court of the
State of Delaware (and each agrees that no such claim, action, suit or other proceeding relating to this Agreement will be brought
by it or any of its Affiliates except in such court), subject to any appeal, provided that if jurisdiction is not then available
in the Chancery Court of the State of Delaware, then any such claim, suit, action or other proceeding may be brought in any Delaware
state court or any federal court located in the State of Delaware and (b) irrevocably and unconditionally submits to the exclusive
jurisdiction of any such court in any such claim, suit, action or other proceeding and irrevocably and unconditionally waives
the defense of an inconvenient forum to the maintenance of any such claim, suit, action or other proceeding. Each of the parties
hereto further agrees that, to the fullest extent permitted by applicable Law, service of any process, summons, notice or document
by U.S. registered mail to such Person’s respective address set forth in Section 15 will be effective service of process
for any claim, action, suit or other proceeding in Delaware with respect to any matters to which it has submitted to jurisdiction
as set forth above in the immediately preceding sentence. The parties hereto hereby agree that a final judgment in any such claim,
suit, action or other proceeding will be conclusive, subject to any appeal, and may be enforced in other jurisdictions by suit
on the judgment or in any other manner provided by applicable Law.

 

    	-6-

    	 

    

 

10.
 Counterparts. This Agreement may be executed in any number of counterparts with the same effect as if all signing
parties had signed the same document. All counterparts shall be construed together and constitute the same instrument. The exchange
of copies of this Agreement and of signature pages by facsimile transmission or other electronic transmission (including email)
shall constitute effective execution and delivery of this Agreement as to the parties and may be used in lieu of the original
Agreement for all purposes. Signatures of the parties transmitted by facsimile transmission or other electronic transmission (including
email) shall be deemed to be their original signatures for all purposes.

 

11.
 Severability. If any part of this Agreement is construed to be in violation of any law, such part shall be modified
to achieve the objective of the parties to the fullest extent permitted and the balance of this Agreement shall remain in full
force and effect.

 

12.
 Entire Agreement. This Agreement supersedes all other prior oral or written agreements between Borrower, Lender,
its affiliates and persons acting on its behalf with respect to the matters discussed herein, and this Agreement and the instruments
referenced herein contain the entire understanding of the parties with respect to the matters covered herein and therein and,
except as specifically set forth herein or therein, neither Lender nor Borrower makes any representation, warranty, covenant or
undertaking with respect to such matters.

 

13.
 Amendments. This Agreement may be amended, modified, or supplemented only by written agreement of the parties. No
provision of this Agreement may be waived except in writing signed by the party against whom such waiver is sought to be enforced.

 

14.
 Successors and Assigns. This Agreement shall be binding upon and inure to the benefit of the parties and their respective
successors and permitted assigns.

 

    	-7-

    	 

    

 

15.
 Notices. Unless otherwise specifically provided for herein, all notices, demands or requests required or permitted
under this Agreement to be given to Borrower or Lender shall be given as set forth as follows:

 

If
to Borrower:

 

201
Route 17 North, 2nd Floor

Rutherford,
NJ 07070, USA

Attention:
John A. Roberts, President & CEO

Facsimile:
(201) 528-9201

Email:
jay.roberts@cgix.com

 

If
to Lender:

 

Jerusalem
Bio-Park

Hadassah
Ein Kerem campus, 1st Kiryat Hadassah

Minrav
Building

Jerusalem,
Israel, 9112001

Attention:
Michael Vidne, CEO

E-mail:
michael@novellusdx.bio

 

16.
 Further Assurances. Each party shall do and perform or cause to be done and performed, all such further acts and
things, and shall execute and deliver all such other agreements, certificates, instruments and documents, as the other party may
reasonably request in order to carry out the intent and accomplish the purposes of this Agreement and the consummation of the
transactions contemplated hereby.

 

[Remainder
of page intentionally left blank]

 

    	-8-

    	 

    

 

IN
WITNESS WHEREOF, the undersigned have executed this Agreement as of the date first set forth above.

 

	 	BORROWER:
	 	 	 
	 	CANCER
    GENETICS, INC.
	 	 	 
	 	By:	/s/
    John A. Roberts
	 	Name: 
    	John
    A. Roberts
	 	Title:
    	Chief
    Executive Officer
	 	 	 
	 	LENDER:
	 	 	 
	 	NOVELLUSDX
    LTD.
	 	 	 
	 	By:	/s/
    Michael Vidne
	 	Name:	Michael
    Vidne
	 	Title:	Chief
    Executive Officer

 

    	-9-

    	 

    

 

EXHIBIT
A

AMENDMENTS
TO CREDIT AGREEMENT AND NOTE

 

The
parties agree that, immediately upon Borrower’s payment to Lender of the One Million Payment, the Credit Agreement shall
be deemed amended as follows with no further action required by any party:

 

		1.	Article
                                         I is amended to incorporate all definitions in that certain Settlement Agreement, dated
                                         October 21, 2019, to which this Exhibit is annexed. All defined terms no longer used
                                         in the Credit Agreement or Note, as amended hereby, shall be deemed deleted.

 

The
definition of Maturity Date shall be deleted in its entirety, and in its place, it shall read as follows: “Maturity Date”
means the date that is nine (9) months after the One Million Payment Date.

 

The
definition of Specified Event of Default shall be deleted in its entirety and in its place, it shall read as follows: “Specified
Event of Default” shall mean any Event of Default occurring under Section 8.2 (failure to pay when due) and Section
8.6 (bankruptcy), or Section 8.7 (involuntary bankruptcy and non-bankruptcy events).

 

		2.	Article
                                         II – Sections 2.1 shall be deleted in its entirety and in its place, it shall read
                                         as follows: “As of the date hereof, the principal amount of the Loan is $450,000
                                         and no other amount is due hereunder. ”

 

		3.	Section
                                         2.3 shall be deleted in its entirety and in its place, it shall read: “Interest
                                         Rate. No interest shall accrue on the Loans due hereunder. All references to interest
                                         under the Credit Agreement and Note are hereby deleted.”

 

		4.	Section
                                         2.5 is hereby amended to provide that notwithstanding anything in the Note or the Lender’s
                                         records, the total amount due under the Credit Agreement and on the Note as of the One
                                         Million Payment Date is $450,000 in the aggregate, and all other amounts due or which
                                         may have been due prior to such date are discharged, waived and/or forgiven.

 

		5.	Section
                                         2.6 is deleted.

 

		6.	Section
                                         2.7 is deleted in its entirety, and in its place, it shall read as follows: “Commencing
                                         one month after the One Million Payment Date, on each of the first nine monthly anniversaries
                                         of the One Million Payment Date, Borrower shall pay Lender the sum of Fifty Thousand
                                         Dollars, ($50,000) (or an aggregate of Four Hundred Fifty Thousand Dollars ($450,000)).

 

		7.	Article
                                         IV, Section 5.1 and Article VI are deleted in their entireties.

 

		8.	Section
                                         7.1 shall be deleted in its entirety and in its place, it shall read: Optional Conversion
                                         Upon a Specified Event of Default. If a Specified Event of Default shall have occurred,
                                         then, at any time thereafter, Lender may deliver to Borrower written notice of Lender’s
                                         election to convert (the “Conversion Notice”) all, but not less than
                                         all, of the Loans then outstanding and unpaid (collectively, the “Converted
                                         Loan”), into shares of Borrower Common Stock (“Conversion Shares”),
                                         in which case the entire aggregate principal amount of the Converted Loan shall convert
                                         into a number of Conversion Shares equal to the aggregate principal amount of such Converted
                                         Loan, together with all accrued and unpaid interest thereon, divided by $ 0.15
                                         (15 cents). The date on which Lender delivers a Conversion Notice to Borrower is the
                                         “Conversion Date”. The Conversion Notice shall specify: (i) the aggregate
                                         principal amount of and the aggregate amount of accrued and unpaid interest on the Converted
                                         Loan; (ii) the number of Conversion Shares issuable in respect of such Conversion Notice;
                                         (iii) the name of the Person to whom the Conversion Shares shall be issued (if other
                                         than Lender); and (iv) the physical address or electronic delivery instructions to which
                                         Borrower shall deliver such Conversion Shares.

 

    	-10-

    	 

    

 

		9.	Sections
                                         7.3 and 7.4 are deleted and the method and issuance of the Conversion Shares shall be
                                         governed by the terms of the Settlement Agreement.

 

		10.	Article
                                         VIII is amended to delete in its entirety Sections 8.1, 8.3, 8.4, 8.5, 8.8, 8.9, 8.10,
                                         8.11, 8.13 and 8.14.

 

		11.	Article
                                         IX – Section 9.1 is amended to delete the phrase “including without limitation
                                         all accrued and unpaid interest”.

 

		12.	Article
                                         X is amended to delete in its entirety paragraphs, 10.2, 10.7 and 10.25.

 

		13.	Section
                                         10.5 shall be amended to also refer to the Settlement Agreement in addition to the Loan
                                         Documents

 

		14.	Section
                                         10.19 shall be amended such that any defenses provided by the Settlement Agreement are
                                         not waived.

 

		15.	Section
                                         10.23 shall be deleted in its entirety and in its place, it shall read: Inconsistencies.
                                         All provisions of the Loan Documents shall be construed as being supplementary and complementary
                                         to, and cumulative with, the provisions of the other Loan Documents. However, if there
                                         should be an irreconcilable inconsistency between provisions of the Loan Documents, the
                                         terms and provisions of the Settlement Agreement shall govern.

 

The
parties agree that, immediately upon Borrower’s payment to Lender of the One Million Payment, the Note shall be deemed amended
as follows with no further action required by any party:

 

		1.	The
                                         Heading shall be deleted.

 

		2.	The
                                         first 2 paragraphs of the Note shall be deleted and in its place, it shall read:

 

FOR
VALUE RECEIVED, the undersigned (the “Borrower”), hereby promises to pay to NovellusDX, Ltd., or its registered
assigns (the “Lender”), in accordance with the provisions of the Credit Agreement (as hereinafter defined),
the principal amount of $450,000, being the amount due this date under that certain Credit Agreement, dated as of September 14,
2018 (as amended, restated, extended, supplemented or otherwise modified in writing from time to time, including pursuant to a
Settlement Agreement dated this date, the “Credit Agreement;” the terms defined therein being used herein as
therein defined unless otherwise defined herein), by and between the Borrower and the Lender.

 

No
interest shall accrue on the Loan. All payments of principal shall be made to the Lender in Dollars in immediately available funds.

 

		3.	The
                                         4th paragraph of the Note shall be deleted and in its place, it shall read:
                                         This Note is the Note referred to in the Credit Agreement and the holder is entitled
                                         to the benefits thereof.

 

    	-11-

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00301-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00301-of-00352.parquet"}]]